Hypertension affects a substantial part of the world’s population. Treatment options include lifestyle changes and drug-based therapies. Device-based therapies for hypertension are under development and used within the context of clinical studies and randomized controlled and sham-controlled trials. Research on device-based therapies for hypertension typically use ambulatory blood pressure monitoring (ABPM) as primary endpoint. Key […]
{...} click to continue
Certification Europe issues ISO 9001:2015 Surveillance Assessment report and certificate to dabl Limited stating no issues of nonconformity were detected during the assessment and that dabl’s Quality Management System continues to satisfy the requirements of the company.
{...} click to continue
The dabl ABPM system and ABPM device logistics service obviates hospital trial site visits during this COVID-19 pandemic resulting in uninterrupted workflow. The FDA Guidance on Conduct of Clinical Trials of Medical Products during the COVID-19 Pandemic – updated April 2, 2020 – allows for changes to be made to the investigational plan or protocol […]
{...} click to continue
Meet the dabl team at: Outsourcing in Clinical Trials (OCT) West Coast 2020, Hyatt Regency San Francisco Airport, 3rd-4th March, 2020. We would love to meet you there!
{...} click to continue
Why is dabl® Going RED? Cardiovascular diseases kill 1 woman every 80 seconds yet 80% of these cases may be prevented with education and action. According to the American Heart Association increasing physical activity, healthy eating and regularly monitoring your Blood Pressure will help enormously in preventing cardiovascular disease.
{...} click to continue
Dublin, Ireland, January 24th 2019 – dabl, a company at the forefront of research and development in Blood Pressure Management and data analysis for almost twenty years, today announce an exciting new collaborative project in Wearable Technology. As part of a consortium led by Tyndall National Institute dabl will share in $8.7m (€7.5m) to develop […]
{...} click to continue
Hypertension is a condition that prevails globally and is estimated to affect over one billion people. It occurs irrespective of income status but is more common with advancing age. Physical inactivity and increasing body weight are significant contributory factors to developing hypertension. On this, #WorldCOPDDay it is worth noting the correlation between COPD, hypertension and […]
{...} click to continue
The cost of clinical trials is rising exponentially. The Tufts Centre for the Study of Drug Development has published data that indicates the average cost to develop and secure marketing approval for a new drug now exceeds $2.5 billion. Although the new industry model of outsourcing, in the form of Contract research Organisations, is seen as a step […]
{...} click to continue
Hypertension, otherwise known as Blood Pressure can affect people with Type 1 or Type 2 Diabetes. In most cases Hypertension has no signs or symptoms and this is why it is often referred to as the silent killer. According to the American Diabetes Association 71% of adults with diabetes had a blood pressure of greater than […]
{...} click to continue
Press Release – October 2018 – Dublin dabl Ltd, a globally recognised provider of Centralised Blood Pressure Data Management Systems for Clinical Trials, announces it is certified under ISO 9001: 2015. ISO 9001 is the international standard for a Quality Management System. It ensures that we consistently provide products and services that meet customer and […]
{...} click to continue